NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

RK, Branko used a later larger Stupp trial that accrued from 2006-2009. See https://clinicaltrials.gov/archive/NCT00304031 and see 2013 publication for it here http://ascopubs.org/doi/pdf/10.1200/JCO.2013.49.6968. (data cutoff was January 2011) This is sometimes known as the phase III dose dense trial which used SOC v. SOC w/denser dosing regimen. He did not use the trial that accrued 2001-2003.

Moreover, the UCLA survival data that you suggest Branko use already includes some patients that have received DCVax-L therapy.